Johnathan Oh, Minal Barve, Neil Senzer, Phylicia Aaron, Luisa Manning, Gladice Wallraven, . . . Rodney P. Rocconi. (2020). Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance. Elsevier.
Chicago Style (17th ed.) CitationJohnathan Oh, et al. Long-term Follow-up of Phase 2A Trial Results Involving Advanced Ovarian Cancer Patients Treated with Vigil® in Frontline Maintenance. Elsevier, 2020.
MLA (9th ed.) CitationJohnathan Oh, et al. Long-term Follow-up of Phase 2A Trial Results Involving Advanced Ovarian Cancer Patients Treated with Vigil® in Frontline Maintenance. Elsevier, 2020.
Warning: These citations may not always be 100% accurate.